ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » ARNA Stock Price » ARNA Stock News

Arena Share News

 Arena Pharmaceuticals (mm) Stock Price
ARNA Stock Price
 Arena Pharmaceuticals (mm) Stock Chart
ARNA Stock Chart
 Arena Pharmaceuticals (mm) Stock News
ARNA Stock News
 Arena Pharmaceuticals (mm) Company Information
ARNA Company Information
 Arena Pharmaceuticals (mm) Stock Trades
ARNA Stock Trades

Arena Pharma Finance Chief Hoffman To Leave Company

DOW JONES NEWSWIRES Arena Pharmaceuticals Inc. (ARNA) said its Chief Financial Officer Robert Hoffman has taken a new position in the health-care industry and will leave the company after it reports its full-year 2010 results. Hoffman is a veteran of the biopharmaceutical company, having served as CFO since December of 2005 and having been with the company since 1997. "Robert has built a strong finance team at Arena, and we are focused on ensuring a smooth transition when he departs next month," said President and Chief Executive Jack Lief. Arena said Jennifer Bielasz and Carolyn Felzer will "continue to play key leadership roles in Arena's finance department" in the interim. Arena in January said it planned to cut its U.S. work force by about one-fourth, or 66 employees, as the company continued to focus on regulatory approval of its proposed diet drug lorcaserin. The U.S. Food and Drug Administration had rejected the drug in October because of questions about its effectiveness, as well as the drug's association with breast-tumor growth in female rat studies. Shares of Arena closed at $1.66 and were inactive after hours. The stock has fallen 46% in the past year. -By Nathan Becker, Dow Jones Newswires; 212-416-2855;;

Stock News for Arena (ARNA)
10/07/201516:21:00Harwood Feffer LLP Announces Investigation of Arena Pharmaceuticals...
10/05/201516:29:39Current Report Filing (8-k)
10/05/201516:15:00Arena Pharmaceuticals Announces Retirement of President and CEO
09/30/201508:03:00Biotechnology Equity Picks -- Arena Pharma, Biogen, Omeros, Illumina...
09/29/201509:03:00Market Updates on the Healthcare Sector - Biogen, Depomed, Arena...
09/24/201508:00:00Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin...
09/23/201508:33:00Scanning Stocks from the Healthcare Sector - Amicus Therapeutics...
09/03/201508:00:00Arena Pharmaceuticals to Present at the Wells Fargo 2015 Healthcare...
08/07/201518:21:08Quarterly Report (10-q)
08/05/201516:19:23Current Report Filing (8-k)
08/05/201516:01:00Arena Pharmaceuticals Reports Second Quarter 2015 Financial Results...
07/30/201508:00:00Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results...
07/29/201516:39:28Current Report Filing (8-k)
07/29/201508:00:00Arena Pharmaceuticals Initiates a Phase 2 Clinical Trial of APD334...
07/24/201509:25:00Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma...
07/13/201518:38:41Initial Statement of Beneficial Ownership (3)
07/09/201517:22:52Current Report Filing (8-k)
07/05/201514:18:03Obesity Statistics Take a Wrong Turn in This Latest Study
06/16/201519:56:18Statement of Changes in Beneficial Ownership (4)
06/16/201519:54:53Statement of Changes in Beneficial Ownership (4)

Arena Pharmaceuticals and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations